JPH03279318A - External preparation of skin - Google Patents
External preparation of skinInfo
- Publication number
- JPH03279318A JPH03279318A JP7966090A JP7966090A JPH03279318A JP H03279318 A JPH03279318 A JP H03279318A JP 7966090 A JP7966090 A JP 7966090A JP 7966090 A JP7966090 A JP 7966090A JP H03279318 A JPH03279318 A JP H03279318A
- Authority
- JP
- Japan
- Prior art keywords
- pimple
- skin
- alcohol
- acid
- acne
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 206010000496 acne Diseases 0.000 claims abstract description 28
- 229940079593 drug Drugs 0.000 claims abstract description 10
- 239000003814 drug Substances 0.000 claims abstract description 10
- 239000004094 surface-active agent Substances 0.000 claims abstract description 10
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical group C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims abstract description 5
- 208000002874 Acne Vulgaris Diseases 0.000 claims description 23
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 125000005313 fatty acid group Chemical group 0.000 claims 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract description 24
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract description 12
- 229960004889 salicylic acid Drugs 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 abstract description 8
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 abstract description 8
- 229940055577 oleyl alcohol Drugs 0.000 abstract description 8
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 abstract description 8
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 6
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 abstract description 6
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 abstract description 4
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 abstract description 4
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 abstract description 4
- 239000005642 Oleic acid Substances 0.000 abstract description 4
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 abstract description 4
- 239000004202 carbamide Substances 0.000 abstract description 4
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 abstract description 4
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 abstract description 4
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 3
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003780 keratinization Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 239000004166 Lanolin Substances 0.000 description 14
- 229940039717 lanolin Drugs 0.000 description 14
- 235000019388 lanolin Nutrition 0.000 description 14
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- -1 2-oftadecenol Chemical compound 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000004359 castor oil Substances 0.000 description 8
- 235000019438 castor oil Nutrition 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000006071 cream Substances 0.000 description 7
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 6
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 6
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 6
- 239000002674 ointment Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000001593 sorbitan monooleate Substances 0.000 description 6
- 235000011069 sorbitan monooleate Nutrition 0.000 description 6
- 229940035049 sorbitan monooleate Drugs 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 150000004665 fatty acids Chemical group 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000006210 lotion Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 210000002374 sebum Anatomy 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- CFOQKXQWGLAKSK-KTKRTIGZSA-N (13Z)-docosen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCCO CFOQKXQWGLAKSK-KTKRTIGZSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- CFOQKXQWGLAKSK-UHFFFAOYSA-N 13-docosen-1-ol Natural products CCCCCCCCC=CCCCCCCCCCCCCO CFOQKXQWGLAKSK-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 241000700198 Cavia Species 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 239000004147 Sorbitan trioleate Substances 0.000 description 2
- PRXRUNOAOLTIEF-ADSICKODSA-N Sorbitan trioleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCC\C=C/CCCCCCCC PRXRUNOAOLTIEF-ADSICKODSA-N 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- FATBGEAMYMYZAF-KTKRTIGZSA-N oleamide Chemical compound CCCCCCCC\C=C/CCCCCCCC(N)=O FATBGEAMYMYZAF-KTKRTIGZSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019337 sorbitan trioleate Nutrition 0.000 description 2
- 229960000391 sorbitan trioleate Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ZCHHRLHTBGRGOT-SNAWJCMRSA-N (E)-hex-2-en-1-ol Chemical compound CCC\C=C\CO ZCHHRLHTBGRGOT-SNAWJCMRSA-N 0.000 description 1
- AYQPVPFZWIQERS-VOTSOKGWSA-N (E)-oct-2-en-1-ol Chemical compound CCCCC\C=C\CO AYQPVPFZWIQERS-VOTSOKGWSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- GWSURTDMLUFMJH-FOCLMDBBSA-N (e)-hexadec-1-en-1-ol Chemical compound CCCCCCCCCCCCCC\C=C\O GWSURTDMLUFMJH-FOCLMDBBSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- WXBXVVIUZANZAU-UHFFFAOYSA-N 2E-decenoic acid Natural products CCCCCCCC=CC(O)=O WXBXVVIUZANZAU-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 206010020649 Hyperkeratosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 206010033733 Papule Diseases 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960003328 benzoyl peroxide Drugs 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- AYQPVPFZWIQERS-UHFFFAOYSA-N cis-2-octen-1-ol Natural products CCCCCC=CCO AYQPVPFZWIQERS-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- HOUDCAFABFEPLY-UHFFFAOYSA-N octadeca-9,11,13-trien-1-ol Chemical compound CCCCC=CC=CC=CCCCCCCCCO HOUDCAFABFEPLY-UHFFFAOYSA-N 0.000 description 1
- CKQVRZJOMJRTOY-UHFFFAOYSA-N octadecanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O CKQVRZJOMJRTOY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- LBIYNOAMNIKVKF-FPLPWBNLSA-N palmitoleyl alcohol Chemical compound CCCCCC\C=C/CCCCCCCCO LBIYNOAMNIKVKF-FPLPWBNLSA-N 0.000 description 1
- LBIYNOAMNIKVKF-UHFFFAOYSA-N palmitoleyl alcohol Natural products CCCCCCC=CCCCCCCCCO LBIYNOAMNIKVKF-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960001755 resorcinol Drugs 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- WBHHMMIMDMUBKC-XLNAKTSKSA-N ricinelaidic acid Chemical compound CCCCCC[C@@H](O)C\C=C\CCCCCCCC(O)=O WBHHMMIMDMUBKC-XLNAKTSKSA-N 0.000 description 1
- 229960003656 ricinoleic acid Drugs 0.000 description 1
- FEUQNCSVHBHROZ-UHFFFAOYSA-N ricinoleic acid Natural products CCCCCCC(O[Si](C)(C)C)CC=CCCCCCCCC(=O)OC FEUQNCSVHBHROZ-UHFFFAOYSA-N 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000008417 skin turnover Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940100515 sorbitan Drugs 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- WXBXVVIUZANZAU-CMDGGOBGSA-N trans-2-decenoic acid Chemical compound CCCCCCC\C=C\C(O)=O WXBXVVIUZANZAU-CMDGGOBGSA-N 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野〕 本発明はニキビ治療用の皮膚外用剤に関する。[Detailed description of the invention] [Industrial application field] The present invention relates to an external skin preparation for treating acne.
ニキビは主として思春期に発現する皮膚疾患で病名を尋
常性座瘉といい、臨床的には″上置脂腺系を中心に上孔
に起る慢性の炎症性変化“と定義されている。Acne is a skin disease that primarily occurs during adolescence, and is called acne vulgaris, and is clinically defined as ``chronic inflammatory changes that occur in the upper foramen, centering on the supragen sebaceous gland system.''
ニキビの病因は現在まだ明らかではなく、種々の要因が
複雑にからみあっている皮膚疾患ではあるが一般には、
皮脂分泌過剰、上奏角化、上置内細菌が重要な役割をは
たしていると考えられている。The etiology of acne is still unclear, and although it is a skin disease in which various factors are intricately intertwined, in general,
Excessive sebum secretion, epidermal hyperkeratosis, and epiphylactic bacteria are thought to play important roles.
従って、ニキビ治療の外用剤としては、各要因に対応し
て皮脂分泌抑制剤および抗菌物質を配合したクリーム、
軟膏が一般に多用されている。しかし、既存の各種薬剤
を配合したニキビ治療薬は必ずしも期待した治療効果を
発揮しないのがほとんどである。Therefore, topical preparations for acne treatment include creams containing sebum secretion inhibitors and antibacterial substances depending on each factor;
Ointments are commonly used. However, most of the existing anti-acne drugs that combine various drugs do not always exhibit the expected therapeutic effects.
本発明者らは従来のニキビ治療薬の治療効果を高めるべ
く鋭意研究を重ねた結果、従来のニキビ治療薬に特定の
界面活性剤を配合することにより、ニキビの治療効果を
高め、早期治療をも達成することを見出して本発明を完
成するに至った。The inventors of the present invention have conducted intensive research to improve the therapeutic effects of conventional acne treatment drugs, and have found that by adding a specific surfactant to conventional acne treatment drugs, they can enhance the treatment effect of acne and facilitate early treatment. The present invention was completed based on the discovery that the same can be achieved.
すなわち、本発明は、アクネ用薬剤と、分子中に1個又
は2個以上の不飽和結合を有する脂肪族アルコール残基
又は脂肪酸残基を骨格として持つ界面活性剤を有効成分
として含有してなる皮膚外用剤である。That is, the present invention contains as active ingredients an acne drug and a surfactant having a backbone of an aliphatic alcohol residue or a fatty acid residue having one or more unsaturated bonds in the molecule. It is an external preparation for the skin.
本発明の皮膚外用剤は、いわゆる皮膚外用剤例えば軟膏
として、又は皮膚化粧料例えばクリームローションとし
て皮膚に適用される。The external skin preparation of the present invention is applied to the skin as a so-called external skin preparation, such as an ointment, or as a skin cosmetic, such as a cream lotion.
本発明に用いられるアクネ用薬剤としては、ニキビの原
因のひとつである皮脂腺の導管の過角質化を抑制する作
用を有する化合物、例えば尿素、過酸化ベンゾイル、レ
ゾルシノール、サリチル酸、ビタミンA酸などがあげら
れるが、好ましくはサリチル酸、尿素、レゾルシノール
である。さらに、最も効果の顕著なものはサリチル酸で
ある。The anti-acne drugs used in the present invention include compounds that have the effect of suppressing hyperkeratinization of sebaceous gland ducts, which is one of the causes of acne, such as urea, benzoyl peroxide, resorcinol, salicylic acid, and vitamin A acid. However, salicylic acid, urea, and resorcinol are preferred. Furthermore, the most effective one is salicylic acid.
本発明のアクネ用薬剤の配合量は0.001−15重量
%であるが、好ましくは、0.005〜5重量%である
。最も好ましいサリチル酸の場合は、0.05〜5重量
%が最も好ましい。The amount of the acne drug of the present invention is 0.001-15% by weight, preferably 0.005-5% by weight. For the most preferred salicylic acid, 0.05 to 5% by weight is most preferred.
本発明において分子中に1個又は2個以上の不飽和結合
を有する脂肪族アルコールは、好ましくは炭素数6〜3
6の二重結合を有する直鎖または分岐状のものであり、
代表的なものとして、2−ヘキセノール、2−オクテノ
ール、2−ドブセノール、2−テトラゾセノール、2−
ヘキサデセノール、2−オフタデセノール、パルミトレ
イルアルコール、オレイルアルコール、エルシルアルコ
ール、リシルイルアルコール、エレオステアリルアルコ
ール、リシルイルアルコール、エルシルアルコール、ゲ
ラニオール、リナロール、ビサボロール等を挙げること
ができる。これらの中でオレイルアルコールが最も好ま
しい。In the present invention, the aliphatic alcohol having one or more unsaturated bonds in the molecule preferably has 6 to 3 carbon atoms.
It is a straight chain or branched one having 6 double bonds,
Typical examples include 2-hexenol, 2-octenol, 2-dobcenol, 2-tetrazocenol, 2-
Examples include hexadecenol, 2-oftadecenol, palmitoleyl alcohol, oleyl alcohol, erucyl alcohol, lysyl alcohol, eleostearyl alcohol, lysyl alcohol, erucyl alcohol, geraniol, linalool, bisabolol, and the like. Among these, oleyl alcohol is most preferred.
本発明において分子中に1個又は2個以上の不飽和結合
を有する脂肪酸は、好ましくは炭素数6〜36の二重結
合を有する直鎖または分岐状のものであり、代表的なも
のとしては、オレイン酸、ラノリン脂肪酸、リノール酸
、リシノール酸、リルイン酸、トール油、ウンデジレン
酸、デセン酸、パルミトレイン酸、エルカ酸、ミリスト
レイン酸等が挙げられる。これらの中でオレイン酸が最
も好ましい。In the present invention, the fatty acid having one or more unsaturated bonds in the molecule is preferably a linear or branched fatty acid having a double bond of 6 to 36 carbon atoms, and typical examples include , oleic acid, lanolin fatty acid, linoleic acid, ricinoleic acid, liluic acid, tall oil, undedylenic acid, decenoic acid, palmitoleic acid, erucic acid, myristoleic acid, and the like. Among these, oleic acid is most preferred.
上記本発明の脂肪族アルコールまたは脂肪酸を界面活性
剤とするために付加するものとしては、多価アルコール
、糖、アルキレンオキシド等が挙げられるが、中でもエ
チレンオキシドを代表とするアルキレンオキシドが好ま
しい。多価アルコールの例としては、グリセリン、エチ
レングリコール、プロピレングリコール、ソルビトール
、ポリグリセレン等が挙げられる。糖の例としては、シ
ョ糖、ラフィノーズ等が挙げられる。Examples of substances added to the aliphatic alcohol or fatty acid of the present invention to use as a surfactant include polyhydric alcohols, sugars, alkylene oxides, etc. Among them, alkylene oxides typified by ethylene oxide are preferred. Examples of polyhydric alcohols include glycerin, ethylene glycol, propylene glycol, sorbitol, polyglycerene, and the like. Examples of sugars include sucrose, raffinose, and the like.
以上の本発明の界面活性剤を具体的に、例示すれば以下
のものを挙げることができる。Specific examples of the above-mentioned surfactants of the present invention include the following.
ソルビタンモノオレエート、ソルビタンセスキオレエー
ト、ソルビタントリオレエート、ソルビタンモノヒマシ
油脂肪酸エステル、P、 0. E、 Gl!0)ソル
ビタンモノオレエート、P、 O,E、■ソルビタント
リオレエート、P、 O,E、 (6)ソルビタンモノ
オレエート、P、 0. E、 (60)ソルビタンモ
ノオレエート、P、 O,E。Sorbitan monooleate, sorbitan sesquioleate, sorbitan trioleate, sorbitan monocastor oil fatty acid ester, P, 0. E, Gl! 0) Sorbitan monooleate, P, O, E, ■ Sorbitan trioleate, P, O, E, (6) Sorbitan monooleate, P, 0. E, (60) Sorbitan monooleate, P, O,E.
■ソルビタンヒマシ油脂肪酸エステル、グリセリルモノ
オレエート、グリセリンヒマシ油脂肪酸エステル、グリ
セリルモノオレエート、P、 O,E、 (5)グリセ
リルモノオレエート、P、 0. E、 (1(1)グ
リセリルモノオレエート、P、 O,E、 (15)グ
リセリルモノオレエート、P、 0. E、■グリセリ
ルモノオレエート、P、 0. E。■Sorbitan castor oil fatty acid ester, glyceryl monooleate, glycerin castor oil fatty acid ester, glyceryl monooleate, P, O, E, (5) Glyceryl monooleate, P, 0. E, (1(1) Glyceryl monooleate, P, O, E, (15) Glyceryl monooleate, P, 0. E, ■ Glyceryl monooleate, P, 0. E.
00)ポリグリセリンオリブ油脂肪酸エステル、P、0
゜E、(21モノオレエート、P、0. E、 (6)
モノオレエート、P、 O,E、 (10)モノオレエ
ート、P、 O,E、 (7)オレイルエーテル、P、
O,E、 (10)オレイルエーテル、P、 O,E
、 (15)オレイルエーテル、P、 O,E、 (2
0+オレイルエーテル、P、0゜E、(50)オレイル
エーテル、P、 0.E、 (2)アビエチルエーテル
、P、 O,E、 (5)アビエチルエーテル、P、
0. E、 (10)アビエチルエーテル、P、 0.
E、 (20)アビエチルエーテル、P、 O,E、
(10)ラノリンアルコール、P、 0. E、(至
)ラノリンアルコール、P、 0. E、 (30)ラ
ノリンアルコール、P、O,E、(5)ラノリンアルコ
ール、P、 0. E、 (10)ラノリンアルコール
、P、 0. E、 @)ラノリンアルコール、P。00) Polyglycerin olive oil fatty acid ester, P, 0
゜E, (21 monooleate, P, 0.E, (6)
Monooleate, P, O, E, (10) Monooleate, P, O, E, (7) Oleyl ether, P,
O, E, (10) Oleyl ether, P, O, E
, (15) Oleyl ether, P, O, E, (2
0+oleyl ether, P, 0°E, (50) oleyl ether, P, 0. E, (2) Abethyl ether, P, O, E, (5) Abethyl ether, P,
0. E, (10) abiethyl ether, P, 0.
E, (20) abiethyl ether, P, O, E,
(10) Lanolin alcohol, P, 0. E, (to) lanolin alcohol, P, 0. E, (30) Lanolin alcohol, P, O, E, (5) Lanolin alcohol, P, 0. E, (10) lanolin alcohol, P, 0. E, @) Lanolin alcohol, P.
0、 E、 (40)ラノリンアルコール、P、 O,
E、 (3)ヒマシ油、P、O,E、OO) ヒフ シ
油、P、O,E、(20)l:−マシ油、P、 O,E
。0, E, (40) Lanolin alcohol, P, O,
E, (3) Castor oil, P, O, E, OO) Castor oil, P, O, E, (20) l:- Castor oil, P, O, E
.
(40)ヒマシ油、P、 O,E、 (50)ヒマシ油
、P、 O,E、(60)ヒマシ油、P、 O,E、0
ωラノリン、P、 0. E、 @)ラノリン、P、O
,E、(30)ラノリン、P、 O,E、 (15)オ
レイルアミン、P、 O,E、 (5)オレイン酸アミ
ド、P、 O,E、 (10)オレイン酸アミド。(40) Castor oil, P, O, E, (50) Castor oil, P, O, E, (60) Castor oil, P, O, E, 0
ω lanolin, P, 0. E, @) Lanolin, P, O
, E, (30) lanolin, P, O, E, (15) oleylamine, P, O, E, (5) oleic acid amide, P, O, E, (10) oleic acid amide.
これらの中で、オレイン酸又はオレイルアルコールを骨
格とする界面活性剤が好ましく、中でもP、 O,E、
オレイルエーテルが最も好ましい。Among these, surfactants having oleic acid or oleyl alcohol as a skeleton are preferred, and among them, P, O, E,
Most preferred is oleyl ether.
本発明の上記界面活性剤のHLBは任意に選ぶことがで
きるが、10以上好ましくはlO〜18である。又、配
合量は好ましくは0.1〜5重量%、さらに好ましくは
、0.1〜2重量%の範囲で選定される。The HLB of the surfactant of the present invention can be arbitrarily selected, but is preferably 10 or more, preferably 10 to 18. Further, the blending amount is preferably selected in the range of 0.1 to 5% by weight, more preferably 0.1 to 2% by weight.
本発明の皮膚外用剤には皮脂分泌抑制剤、ゲル化剤、安
定化剤、増粘剤、多価アルコール等の保湿剤、収斂剤、
pH調整剤、香料、色素、アルコール、水などの通常使
用される補助成分や本発明以外の抗菌剤、界面活性剤等
を、本発明の効果を損なわない範囲で適宜配合すること
ができる。The skin external preparation of the present invention includes sebum secretion suppressants, gelling agents, stabilizers, thickeners, humectants such as polyhydric alcohols, astringents,
Commonly used auxiliary components such as pH adjusters, fragrances, pigments, alcohol, and water, as well as antibacterial agents and surfactants other than those of the present invention, may be appropriately blended within the range that does not impair the effects of the present invention.
作用
本発明の皮膚外用剤はその症状にもよるが、通常1日に
1〜数回、1回に0.1■〜0.5g程度を患部に塗布
すればよい。この塗布方法により通常軽度のニキビは数
日で、重症のニキビでも2〜3週間で消失する。また本
治療方法を施しても副作用は全く観察されない。Effects The skin external preparation of the present invention may be applied to the affected area in an amount of about 0.1 to 0.5 g, usually once to several times a day, depending on the symptoms. With this application method, mild acne usually disappears in a few days, and even severe acne disappears in 2 to 3 weeks. Furthermore, no side effects are observed even when this treatment method is applied.
以下、本発明の優れた効果を明らかにするために実施例
および比較例を用いて評価試験を行った。配合量は重量
%である。Hereinafter, evaluation tests were conducted using Examples and Comparative Examples in order to clarify the excellent effects of the present invention. The blending amount is in weight%.
試験方法−
モルモット皮膚を用いた表皮のターンオーバー速度測定
方法。Test method - Method for measuring epidermal turnover rate using guinea pig skin.
アルピノモルモットを1群8匹として評価に用いた。モ
ルモットの腹部皮膚を刺毛後、蛍光色素であるダンジル
クロライドを5重量%配合した白色ワセリン軟膏を0.
1i/ctl、24時間、閉塞塗布した。被験物質は実
施例1および比較例1〜3を1日1回0.3−づつダン
ジルクロライド塗布部に重ね塗りし、皮膚の角質総ター
ンオーバー速度はダンジルクロライドが消失するまでの
日数をもって評価した。Alpino guinea pigs were used in the evaluation with 8 animals per group. After pricking the abdominal skin of the guinea pig, apply 0% white petrolatum ointment containing 5% by weight of the fluorescent dye danzyl chloride.
Occlusive application was applied at 1 i/ctl for 24 hours. As for the test substances, Example 1 and Comparative Examples 1 to 3 were applied once a day at a rate of 0.3 to 100% on the area where danzyl chloride was applied, and the total skin turnover rate was determined by the number of days until danzyl chloride disappeared. evaluated.
一試験結果
表−1の結果から明らかなように、モルモットを用いた
評価により、サリチル酸およびP OE (15)オレ
イルエーテルの両者を含有する実施例1は比較例1〜3
と比べて表皮のターンオーバーを速めることが明らかと
なった。As is clear from the results in Test Results Table 1, according to the evaluation using guinea pigs, Example 1 containing both salicylic acid and P OE (15) oleyl ether was superior to Comparative Examples 1 to 3.
It has been shown that the turnover of the epidermis is accelerated compared to the previous study.
表1
一効果測定方法一
顔面にアクネのみられる15〜32歳までの男女計10
名を一群とし、化粧石鹸を用いて顔面をよく洗浄した後
、皮脂の上にのみ、試料を1日に1〜3回塗布せしめた
。Table 1: Effect measurement method: Total of 10 men and women aged 15 to 32 with facial acne
After thoroughly washing the face with cosmetic soap, the sample was applied only on the sebum 1 to 3 times a day.
面飽、丘疹、膿庖の3症状について観察し、その個々の
所見の程度をそれぞれ高度(4)、中程度(3)、軽度
(2)、軽微(1)、なしく0)の5段階に分けて評価
した。経過観察は、治療前、治療1週間後、2週間後、
3週間後、4週間後の各回に行い使用前に比較して使用
試料による症状の改善度を著しく軽快(+++) 、が
なり軽快(++)、やや軽快(+)、不変(±)、悪化
(−)の5段階に分けた。The three symptoms of skin irritation, papules, and pus are observed, and the severity of each finding is graded into five levels: severe (4), moderate (3), mild (2), slight (1), and none (0). It was evaluated separately. Follow-up observation is before treatment, 1 week after treatment, 2 weeks after treatment,
After 3 weeks and 4 weeks, the degree of improvement in the symptoms of the sample used was compared to before use: markedly reduced (+++), slightly improved (++), slightly improved (+), unchanged (±), worsened. It was divided into 5 levels (-).
上記の観察経過を総合的に判断してきわめて有用(◎)
、かなり有用(○)、やや有用(△)、無効(×)の4
段階に総合評価した。Extremely useful (◎) by comprehensively evaluating the above observation progress
, Very useful (○), Somewhat useful (△), Ineffective (×) 4
Comprehensive evaluation was performed in stages.
表2
く製造方法〉
■〜■、および■〜[相]を70℃で加熱溶解し、これ
に、■、■、■の一部を同じ<70℃にて加熱溶解した
ものを添加混合して、ホモミキサーで乳化する。これに
0の残部に溶かした■を添加し、次いで■を徐添加し、
ホモミキサーで処理して乳液タイプの化粧料を得た。Table 2 Manufacturing method〉 ■~■ and ■~[phase] were heated and dissolved at 70°C, and a portion of ■, ■, and ■ that had been heated and melted at the same <70°C was added and mixed. and emulsify with a homomixer. To this, add ■ dissolved in the remainder of 0, then slowly add ■,
A milky lotion type cosmetic was obtained by processing with a homomixer.
表2から明らかなように、本発明に係る化粧料は、アク
ネの治療効果に優れていることが分かるさらに、実施例
を挙げて本発明に係る外用剤について説明する。配合量
は同じく重量%である。As is clear from Table 2, the cosmetic composition according to the present invention has an excellent therapeutic effect on acne.Furthermore, the external preparation according to the present invention will be explained with reference to Examples. The blending amount is also expressed in weight %.
実施例3
ステアリルアルコール 5.0ステアリ
ン酸 2.0水添ラノリン
2.0スクワラン
6.0ミリスチン酸イソプロピル
4.0ポリオキシエチレン(25モル)3.0セ
チルアルコールエーテル
モノステアリン酸グリセリン 2.0POE(
10)モノオレート 0.3サリチル酸
5.0プロピレングリコール
5.0ブチルパラベン
0.2ジブチルヒドロキシトルエン 0
.05香料 0.5エ
チニルエストラジオール 0.1イオン交換
水 64.85上記処方成分を常
法により製造してクリーム状化粧料を得た。得られた化
粧料は、アクネの治療効果に優れていた。Example 3 Stearyl Alcohol 5.0 Stearic Acid 2.0 Hydrogenated Lanolin
2.0 squalane
6.0 Isopropyl myristate
4.0 Polyoxyethylene (25 mol) 3.0 Cetyl Alcohol Ether Monostearate Glycerin 2.0 POE (
10) Monooleate 0.3 salicylic acid
5.0 Propylene glycol
5.0 Butylparaben
0.2 dibutylhydroxytoluene 0
.. 05 Perfume 0.5 Ethinyl estradiol 0.1 Ion-exchanged water 64.85 A cream cosmetic was obtained by manufacturing the above prescription ingredients by a conventional method. The obtained cosmetic had excellent acne treatment effects.
実施例4
塩酸ピリドキシン 0.1沈降イオ
ウ 2.0アルコール
15.0メチルセルロース水溶液
(1%)5.0グリセリン 5
.0ポリオキシエチレン(15モル)0.4オレイルア
ルコールエーテル
サリチル酸 0.1ヘキサク
ロロフエン 0.05メチルパラベン
0.1香料
0.1イオン交換水
72.15上記処方成分を常法により製造して化粧
水を得た。得られた化粧水は、アクネの治療効果に優れ
ていた。Example 4 Pyridoxine hydrochloride 0.1 Precipitated sulfur 2.0 Alcohol
15.0 Methyl cellulose aqueous solution (1%) 5.0 Glycerin 5
.. 0 Polyoxyethylene (15 moles) 0.4 Oleyl alcohol ether salicylic acid 0.1 Hexachlorophene 0.05 Methyl paraben 0.1 Fragrance
0.1 ion exchange water
72.15 A lotion was obtained by manufacturing the above prescription ingredients by a conventional method. The obtained lotion had excellent acne treatment effects.
実施例5(乳液の製造)
(A)の成分 配合量(重量%)セタノー
ル 1.5ステアリン酸
1.0パルミチン酸
0.5液状ラノリン
1.0スクワラン 2.
0ミリスチン酸イソプロピル 1.0モノス
テアリン酸グリセリン 1.5Tween20
0.5オレイルアルコール
3.0EO(10モル)付加物
サリチル酸 0.5防腐剤及
び香料 適量(B)の成分
プロピレングリコール 3.0ポリエチ
レングリコール400 2.0トリエタノール
アミン 1.0精製水
81.5上記(A)の各成分を混合して
混合物を得た。Example 5 (Production of emulsion) Component (A) Amount (wt%) Setanol 1.5 Stearic acid
1.0 palmitic acid
0.5 liquid lanolin
1.0 Squalane 2.
0 Isopropyl myristate 1.0 Glyceryl monostearate 1.5 Tween20
0.5 oleyl alcohol
3.0 EO (10 mol) adduct salicylic acid 0.5 Preservatives and fragrances Appropriate amount (B) component Propylene glycol 3.0 Polyethylene glycol 400 2.0 Triethanolamine 1.0 Purified water
81.5 Each component of (A) above was mixed to obtain a mixture.
別に、同様にして(B)の混合物を得た。(A)の混合
物及び(B)の混合物を各別に70℃に加熱溶解し、(
A)の混合物を(B)の混合物の中に加え、乳化機によ
り乳化したのち熱交換、冷却して乳液を製造した。Separately, a mixture (B) was obtained in the same manner. The mixture of (A) and the mixture of (B) were individually heated and dissolved at 70°C, and (
The mixture of A) was added to the mixture of (B) and emulsified using an emulsifier, followed by heat exchange and cooling to produce a milky lotion.
この乳液はアクネの治療に著効を示した。This emulsion showed remarkable efficacy in treating acne.
実施例6(クリームの製造)
(A)の成分 配合量(重量%)セタノー
ル 4.0ステアリン酸
2.0ワセリン
4.0流動パラフイン
10.0ミリスチン酸イソプロピル
5.0モノステアリン酸グリセリン 3.0
オレイルアルコール 0.5EO(
15モル)付加物
POE(10)ラノリンアルコール 0.1サリチ
ル酸 1.0(B)の成分
グリセリン 5.0プロピレング
リコール 5.0水酸化カリウム
0.2精製水
60.2実施例5と同様にしてクリームを製造し
た。このものもアクネの治療に著効を示した。Example 6 (Manufacture of cream) Ingredients (A) Amount (wt%) Setanol 4.0 Stearic acid
2.0 Vaseline
4.0 liquid paraffin
10.0 Isopropyl myristate
5.0 Glyceryl monostearate 3.0
Oleyl alcohol 0.5EO (
15 mol) Adduct POE (10) Lanolin alcohol 0.1 Salicylic acid 1.0 Component of (B) Glycerin 5.0 Propylene glycol 5.0 Potassium hydroxide
0.2 Purified water
60.2 A cream was prepared in the same manner as in Example 5. This product also showed remarkable efficacy in treating acne.
実施例7(クリームの製造)
(A)の成分 配合量(重量%)セタノー
ル 4.0ステアリン酸
2.0ワセリン
4.0流動パラフイン
10.0ミリスチン酸イソプロピル
5.0モノステアリン酸グリセリル 3.0オ
レイルアルコール 0.1EO(2
0モル)付加物
ポリグリセリルモノオレート 0.1サリチル
酸 1.5(B)の成分
グリセリン 5.0プロピレン
グリコール 5.0水酸化カリウム
0.2精製水
60.1実施例5と同様にしてクリームを製
造した。このものもアクネの治療に著効を示した。Example 7 (Manufacture of cream) Ingredients (A) Amount (wt%) Setanol 4.0 Stearic acid
2.0 Vaseline
4.0 liquid paraffin
10.0 Isopropyl myristate
5.0 Glyceryl monostearate 3.0 Oleyl alcohol 0.1 EO (2
0 mol) Adduct polyglyceryl monooleate 0.1 Salicylic acid 1.5 Component of (B) Glycerin 5.0 Propylene glycol 5.0 Potassium hydroxide
0.2 Purified water
60.1 A cream was prepared in the same manner as in Example 5. This product also showed remarkable efficacy in treating acne.
実施例8(軟こう)
成分 配合量(重量%)固体パラ
フィン 10.0ピースワツクス
10.0スクワラン
10.0P OE (6)ソルビタン
モノオレート1.0ソルビタンモノオレート1.0
サリチル酸 1.0香料
適量ワセリン
67.0上記酸分を混合し、混合物
を80℃に加熱溶解した後、攪拌冷却を行い軟膏を得た
。このものはアクネの治療に著効を示した。Example 8 (soft ointment) Ingredients Amount (wt%) Solid paraffin 10.0 piece wax 10.0 squalane
10.0P OE (6) Sorbitan monooleate 1.0 Sorbitan monooleate 1.0 Salicylic acid 1.0 Fragrance
Appropriate amount of Vaseline
67.0 The above acid components were mixed, the mixture was heated and dissolved at 80°C, and then cooled with stirring to obtain an ointment. This product was highly effective in treating acne.
実施例9〜16
P OE (15)モノオレート 0.2gをエタノー
ル25.0gに溶解し、これにポリエチレングリコール
(PEG −600) 15.0gを添加溶解後、尿素
1.0gを精製水10.0gに溶かした溶液を加える。Examples 9 to 16 Dissolve 0.2 g of P OE (15) monooleate in 25.0 g of ethanol, add and dissolve 15.0 g of polyethylene glycol (PEG-600), then add 1.0 g of urea to 10.0 g of purified water. Add the solution dissolved in.
ついでカルボキシビニルポリマー(カルボポール940
) 0.8gとヒアルロン酸0.1gを精製水20.
0 gに溶かした溶液を添加して攪拌混合したのち、さ
らに精製水27.7 gを加え、トリエタノールアミン
0.2gで中和することによりゲル状の外用剤を得た。Then carboxyvinyl polymer (Carbopol 940
) 0.8g and hyaluronic acid 0.1g in purified water 20.
After adding 0 g of the solution and stirring and mixing, 27.7 g of purified water was further added and neutralized with 0.2 g of triethanolamine to obtain a gel-like external preparation.
同様にしてP OE (15)モノオレート0.2〜2
.0%を含有するゲル軟膏を得た。それらの配合量を実
施例9〜16として表に示した。Similarly, P OE (15) Monooleate 0.2-2
.. A gel ointment containing 0% was obtained. Their blending amounts are shown in the table as Examples 9 to 16.
(以下余白)
〔発明の効果〕
本発明の皮膚外用剤はニキビ治療効果(こ優れ、安定性
・安全性良好である。(Hereinafter in the margin) [Effects of the Invention] The skin external preparation of the present invention has excellent acne treatment effects and good stability and safety.
Claims (1)
飽和結合を有する脂肪族アルコール残基又は脂肪酸残基
を骨格として持つ界面活性剤とを有効成分として含有し
てなる皮膚外用剤。(1) For external use on the skin, containing as active ingredients a drug for acne and a surfactant whose skeleton is an aliphatic alcohol residue or fatty acid residue having one or more unsaturated bonds in the molecule. agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7966090A JPH03279318A (en) | 1990-03-28 | 1990-03-28 | External preparation of skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7966090A JPH03279318A (en) | 1990-03-28 | 1990-03-28 | External preparation of skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03279318A true JPH03279318A (en) | 1991-12-10 |
Family
ID=13696310
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7966090A Pending JPH03279318A (en) | 1990-03-28 | 1990-03-28 | External preparation of skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH03279318A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549888A (en) * | 1994-01-31 | 1996-08-27 | Procter & Gamble | Aqueous topical anti-acne compositions of low pH |
-
1990
- 1990-03-28 JP JP7966090A patent/JPH03279318A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5549888A (en) * | 1994-01-31 | 1996-08-27 | Procter & Gamble | Aqueous topical anti-acne compositions of low pH |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1562531B1 (en) | Topical skin care composition | |
US4545990A (en) | Anti-acne composition | |
US6040347A (en) | Treatment of seborrhoea/cutaneous disorders with octoxyglycerol | |
JPH09506865A (en) | New composition | |
JP2519988B2 (en) | Pharmaceutical composition, and therapeutic agent for skin diseases and cosmetic containing the composition | |
US6495602B1 (en) | Topical pharmaceutical base with anti-pruritic and/or anti-inflammatory drugs | |
JPH0244453B2 (en) | ||
JP2937667B2 (en) | Skin external preparation for acne vulgaris | |
JPH0327532B2 (en) | ||
EP3411014B1 (en) | New topical compositions comprising usnic acid and their use in therapy | |
JPH03178916A (en) | Skin external agent | |
JPH01311014A (en) | Antimicrobial skin drug for external use | |
US6977081B1 (en) | Facial cream composition containing allantoin | |
JPH11269034A (en) | Skin prepafation for external use for improving acne | |
WO1999001137A1 (en) | Azelastine hydrochloride-containing percutaneous preparation having good percutaneous absorbability and reduced skin irritation | |
KR950003611B1 (en) | Antimycotic external lmidazole preparations | |
JPH03279318A (en) | External preparation of skin | |
JPH04360820A (en) | Cosmetic | |
JP3031990B2 (en) | Anti-inflammatory analgesic cream composition | |
JPH07206658A (en) | Therapeutic agent for acne vulgaris | |
JPH10279421A (en) | Preparation for external use for skin | |
CN110944649B (en) | Use of rhamnose and its derivatives as antifungal agents | |
JPH05186328A (en) | Skin washing and cleanly wiping agent composition | |
JPS63183518A (en) | Composition for hair | |
JPH03157311A (en) | Cosmetic for common acne |